Palanca, A., Ampudia-Blasco, F., Calderon, J., Sauri, I., Martinez-Hervas, S., Trillo, J., . . . Real, J. (2023). Real-World Evaluation of GLP-1 Receptor Agonist Therapy Persistence, Adherence and Therapeutic Inertia Among Obese Adults with Type 2 Diabetes.
Citación estilo ChicagoPalanca, A., FJ Ampudia-Blasco, JM Calderon, I. Sauri, S. Martinez-Hervas, JL Trillo, J. Redon, y JT Real. Real-World Evaluation of GLP-1 Receptor Agonist Therapy Persistence, Adherence and Therapeutic Inertia Among Obese Adults With Type 2 Diabetes. 2023.
Cita MLAPalanca, A., et al. Real-World Evaluation of GLP-1 Receptor Agonist Therapy Persistence, Adherence and Therapeutic Inertia Among Obese Adults With Type 2 Diabetes. 2023.
Precaución: Estas citas no son 100% exactas.